CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study
First-in-human Prospective Study to Assess the Safety and Efficacy of the CEM-Cage and CEM-Plate
Sponsor: Albany Medical College
Listed as NCT04883411, this NA trial focuses on Intervertebral Disc Disorder Cervical and Neck Pain and remains actively recruiting participants. Sponsored by Albany Medical College, it has been updated 10 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
May 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — May 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
-
Aug 2023 — Dec 2023 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jun 2023 — Aug 2023 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Feb 2023 — Jun 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2022 — Feb 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Jun 2022 [monthly]
Not Yet Recruiting NA
-
Jun 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Albany Medical College
- IGEA
- ReVivo Medical, Corp.
- The Cleveland Clinic
For direct contact, visit the study record on ClinicalTrials.gov .